Who Won in the COVID-19 Lockdowns? Beverage

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
244
Who Won in the COVID-19 Lockdowns? Beverage Makers

NetworkNewsWire Editorial Coverage: The downside of the coronavirus pandemic and how crippling it was to certain industries has been well documented, but it should not be overlooked that some companies benefited from lockdowns and a focus on healthier habits. Beverage makers, particularly those emphasizing health and alternatives to carbonated sodas, saw a spike in sales as consumers stocked up bottled water, sports drinks and more. Higher demand created an exceptionally attractive market climate and rising revenue for The Alkaline Water Company Inc. (NASDAQ: WTER)(CSE: WTER) (Profile), the U.S.’s largest independent alkaline water company, and its Alkaline88(R) brand. Bigger peers lent further credence to the trend, as evidenced by impressive financial reports from beverage makers such as Keurig Dr Pepper Inc. (NASDAQ: KDP), Celsius Holdings Inc. (NASDAQ: CELH), NewAge Inc. (NASDAQ: NBEV) and National Beverage Corp. (NASDAQ: FIZZ), many of which have leaned on acquisitions to fuel their growth.

With sales surging 28% in full-year 2020 to $41.1 million, WTER is now the largest independent alkaline water company in America.
Alkaline water is an emerging market forecast to reach $1 billion by 2022.
On average, each American drank 43.7 gallons of bottled water in 2019, contributing to $34.6 billion in industry sales.
NBA icon Shaquille O’Neal has become an equity partner in WTER; will serve as advisor, marquee brand ambassador.


The Dominant Player in Alkaline Water

In 2019, bottled water for the fourth consecutive year was the most popular beverage in America by volume, outselling carbonated soft drinks yet again, according to Beverage Marketing Corporation; sales in 2019 reached $34.6 billion. Data from market research firm Statista shows that 88% of Americas drink water every day, and 26% buy name brand water as part of drinking, on average 43.7 gallons, of bottled water in 2019. That’s about 15.3 ounces per day for every person in the country.

The megatrend the water majors are now trying to capture is the increasing consumer health consciousness towards enhanced water as a replacement for sugary drinks, a trend that was emphasized by the pandemic. Fact is that people bought more of or were introduced to value-added water for the first time during COVID-19 lockdowns for any number of reasons, and many of those consumers have now incorporated these functional beverages as part of their lifestyle.

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) is the largest independent player in the alkaline water market with expectations of reaching $1 billion by next year. As the name implies, the Scottsdale, Arizona-based company specializes in producing drinking water with trace minerals and electrolytes. Its “secret sauce” is in using technology to offer water with an alkaline pH of 8.8, compared to a neutral pH of 7.0 for regular drinking water. The higher pH is believed by advocates to have a bevy of benefits, potentially slowing the aging process, regulating the body’s pH level (neutralizing acidity commonly presented in some diseases) and deactivating pepsin, a principal culprit in acid reflux, although WTER does not make any of these claims.

In 2019, WTER widened its portfolio beyond its flagship Alkaline88 brand with the launch of six flavor-infused products branded A88 Infused(TM). The products are sold in an estimated 75,000 retail stores, which while impressive, leaves plenty of head room for growth as it represents only 8% of all retail and hospitality outlets available to consumers. Management has a goal of reaching 90,000–100,000 retail locations in the next year. Any bigger peer looking for immediate market share could leverage WTER’s existing distribution — plus its direct-to-store Delivery (“DSD”) platform that now reaches over 10,000 customers — combine it with their network and dominate the alkaline water market segment.

Customers Keep Coming Back for More

The idea of brand awareness and lifestyle changes related to water during the coronavirus pandemic was put on full display by independent data showing 31% of the people who drank Alkaline88 during the 52-week period ended March 6, 2021, were first-time buyers. Furthermore, the research showed that almost half (47%) of the people who tried Alkaline88 during that time span purchased the water a minimum of four times.

The Alkaline Water Company checks all the boxes with respect to social culture and brand loyalty today. Millennials and younger generations are passionate about ethos and factor that into decision making about purchases and sticking with brands. The company adheres to the most stringent industry guidelines enforced by individual states, Food and Drug Administration, Environmental Protection Agency and International Bottled Water Association (“IBWA”). WTER was the first company in the industry to offer environmentally friendly aluminum packaging and even redesigned its ionization system to use less power and water.

Shaquille O’Neal Joins the Team

Shaquille O’Neal is known for many things, including his Hall of Fame basketball career, humor and insight as an NBA analyst and business acumen that has resulted in a branded empire. He’s widely sought after to endorse products as an A-list brand influencer with a fan base of millions of followers. Shaq is in a position to be selective as to which brands he chooses to endorse. He currently stars in commercials for the General, Icy Hot, Papa John’s, Epson, Ring and Carnival Cruise Lines among other tier-one brands.

As he said in a 2018 interview with HBO Real Sports, O’Neal won’t promote a product unless he genuinely likes it or uses it himself. “If I am going to sell to the people, I have to be honest to the people,” O’Neal said during the interview.

That speaks volumes for Alkaline88, as Shaq recently entered a three-year partnership with the company. According to the agreement, O’Neal is now an equity partner in WTER, advisor and marquee brand ambassador. “Alkaline88 is an innovative product in the water category and I am so excited to partner with The Alkaline Water Company to help raise their game to new heights,” said O’Neal. “I am humbled by the opportunity to join the Advisory Board while also being a brand ambassador.”

“[Shaquille’s] reputation as an astute investor, larger-than-life brand partner, and phenomenal ambassador makes this partnership extremely exciting,” said Aaron Keay, Chairman of The Alkaline Water Company. “We want to welcome Shaquille to the Company’s advisory board and believe his positive presence and global outreach will enable Alkaline88 to aggressively push our growth trajectory even faster.”

Growing Sales and a Multiple Story

With 47% customer retention, Alkaline88 can become a household brand through additional exposure. Shaq certainly brings that to the table as a strong complement to other partnerships and team additions being made. For instance, WTER recently partnered with Hensley Beverage Company for DSD throughout the state of Arizona.

All this is translating to improved sales, including reporting record numbers in the last full year. Q4 2020 revenue totaled $12.1 million, representing 51% year-over-year growth, while sales for all of 2020 were $41.1 million, 28% higher than 2019. These sales figure are particularly relevant in the food and beverage industry as a quantifiable metric of value. Beverage companies traditionally sell between four to six times gross revenue.

In Q3 fiscal 2021, which ended December 31, 2020, the company reported record revenue of $10.2 million, up 20% from a year earlier. Even factoring zero growth resulting from WTER’s recent partnership announcements, which seems extremely unlikely, the company’s FY 2021 forecast would be approximately $41 million, holding steady with last year’s performance. Currently, WTER’s market cap is an estimated $105 million, or 2.5x gross revenue. In a market that has seen segment leaders such as Core (see below) and Essentia (by Nestle) acquired at highly favorable multiples, The Alkaline Water Co. stands out as a potentially undervalued takeover candidate.

Capitalizing on the Trend in Beverages

The writing has been on the wall for two decades that consumer trends were headed away from sugary drinks and straight toward more flavorful and functional waters that are perceived as far healthier. Beverage companies have had to adapt, and the majors have shown that they’re not afraid to open their checkbooks in order to carve back some of the evaporating soda revenue via value-added waters.

Keurig Dr Pepper Inc. (NASDAQ: KDP) made its foray into the premium water market in September 2018, agreeing to pay $525 million in stock to acquire CORE(R) Nutrition LLC. In its three years in business, CORE quickly emerged as a leading player with its two flagship products: CORE Hydration, a premium, nutrient-enhanced bottled water, and CORE Organic, USDA-certified organic enhanced fruit hydration. The two were already close allies, with KDP managing about two-thirds of CORE’s U.S. distribution pre-acquisition. After posting an 11% increase in company-wide net sales to $2.9 billion in Q1 2021, KDP increased its outlook for 2021 net sales growth to 4%-6%, from prior guidance of 3%-4%.

Celsius Holdings Inc. (NASDAQ: CELH), a maker of five certified kosher and vegan beverage lines in the performance energy beverage sector, showed this month that 2021 got off to a great start. The Boca Raton, Florida-based company reported 78% revenue growth in Q1 to $50 million compared to $28.2 million in Q1 2020. Domestic revenue surged 101% year-over-year to $39.0 million during the quarter. International sales rose 25%, including 22% growth in Nordic sales to $10.4 million where the launch of a new Tropical Twist flavor late in March helped offset stocking voids related to COVID-19 lockdowns.

NewAge Inc. (NASDAQ: NBEV) has a storied history dating back to 2003 when the company was originally formed as a beverage distributor. Adding its first product, Aspen artisanal water sourced from the Colorado Rocky Mountains, in 2004, the company has since grown into a global diversified organic and healthy products company centered on helping people to live healthy. Owing largely to closing the acquisition of ARIIX and four other e-commerce/direct selling companies in November, sales exploded in the first quarter of 2021, jumping 97% from the year prior quarter to $125.5 million as the company eyes its goal of annual revenue over $500 million.

National Beverage Corp. (NASDAQ: FIZZ) is best known today for its sparkling waters, juices and energy drinks, but its origins go back nearly 40 years with its flagship brand being Shasta carbonated sodas. Today, the company remains a sparkling water juggernaut that controls about 15% of the market despite having to overcome a frivolous lawsuit in 2018 that temporarily tarnished the LaCroix water brand. The COVID-19 pandemic didn’t slow sales at FIZZ as evidenced by the best Q3 (ended Jan. 30, 2021) ever for the company with sales of $246 million, led by LaCroix sparkling water.

As the functional water sector grows, companies that consistently meet key performance indicators will most certainly be those catching the attention of majors when they start looking to score big in the revenue and profits game.

For more information about The Alkaline Water Company, please visit The Alkaline Water Company.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer


Alkaline Water Company Inc. (WTER) Stock Research Links

WTER Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading